                         SEQUENCE LISTING

<110>  Faron Pharmaceuticals Oy
 
<120>  METHOD FOR DETERMINING PATIENT'S RESPONSIVENESS TO TYPE I 
       INTERFERON TREATMENT AND USE OF TYPE I INTERFERON TO TREAT 
       PATIENT HAVING SPECIFIED SINGLE NUCLEOTIDE POLYMORPHISM

<130>  AP107638PC

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  1001
<212>  DNA
<213>  Homo sapiens

<400>  1
gaggctgagg cagagaattg cttgaacctg ggaggtggag gttgcagtga gccaagaccg       60

cactactgca ctccagcctg ggcaacagag cgagactccc gtctcaaaaa aaaaaaaaaa      120

aaaaaatagt aagcatacct catagagcag ttgcaaggga aaggtaaatt atatataaag      180

caccaagagt catgcccagc atatagtaag catggtgtaa ctgttagctg ttattattgc      240

tgtcatcatc atcaactgca tcatcattca atctcattaa gtttattttt tattttttta      300

gaggcaaggt ctcgctaagg gctggaatgc agtggctatt cacaggtgca gtcataatgc      360

actacagtct gaaactcctg agctcaaaca gtcgtcctgc ctaagcttcc ccagtagctg      420

ggattacaag cgtgcatccc tgtgccccag tgattaagtt ttattatgta gaaaataaag      480

agcaaacagt acagctgata yggactctct ctctcttttt tttttttttt aagaattttc      540

ataacttttt agcctggcca tttcctaacc tgccaccgtt ggaagccatg gatatggtgg      600

aggtcattta catcaacaga aagaagaaag tgtgggatta taattatgat gatgaaagtg      660

atagcgatac tgaggcagcg cccaggacaa gtggcggtgg ctataccatg catggactga      720

ctgtcaggcc tctgggtcag gcctctgcca cctctacaga atcccagttg atagacccgg      780

agtccgagga ggagcctgac ctgcctgagg ttgatgtgga gctccccacg atgccaaagg      840

acagccctca gcagttggaa ctcttgagtg ggccctgtga gaggagaaag agtccactcc      900

aggacccttt tcccgaagag gactacagct ccacggaggg gtctgggggc agaattacct      960

tcaatgtgga cttaaactct gtgtttttga gagttcttga t                         1001


<210>  2
<211>  51
<212>  DNA
<213>  Homo sapiens

<400>  2
taaagagcaa acagtacagc tgatayggac tctctctctc tttttttttt t                51


